Investigates diverse T helper 2 memory cell subsets in asthma, suggesting new therapeutic targets.
Asthma is one of the most common chronic respiratory diseases. Clinical studies have shown that asthma represents a spectrum of inflammatory phenotypes, including predominantly eosinophilic, mixed eosinophilic/neutrophilic, and paucigranulocytic signatures. To investigate the mechanism underlying the heterogeneity of inflammatory phenotypes in asthma, we employed a well-established house dust mite (HDM) challenge model in mice and performed Il13-Cre-mediated lineage-tracing of T helper 2 tissue resident memory cells (Th2-TRMs) in the lung. The lineage-labelled Th2-TRMs were HDM-specific based on Derp1 tetramer labeling and their quick activation in response to HDM stimulation in precision-cut lung slices prepared from mice previously challenged with HDM. Since allergen-specific Th2-TRMs are a central mediator of anamnestic inflammation in asthma, we investigated the molecular phenotypes of IL13-lineage labelled Th2-TRMs by Single cell RNA sequencing (scRNAseq). We identified a major TRM2 subset (Gata3+ only) and additional subsets that co-expressed specific markers of Th1 (TRM2+1), Th17 (TRM2+17), and Treg (TRM2+reg) lineages, which reveals significant heterogeneity of allergen-specific, Th2-TRMs in the lung. By assessing the kinetics of marker expression among Il13-lineage labelled, CD4+ T cells following HDM challenges, we found that the Th cells co-expressing Th2 and Th17 lineage markers were generated in the acute phase of inflammation and subsequently established as TRM2+17 subset in the lung over time. Ongoing experiments aim to study how the heterogeneity of Th2-TRMs is regulated and whether different subsets play distinct roles in eosinophilic and neutrophilic inflammation upon HDM re-challenges. Our ultimate goal is to identify novel mechanisms underlying the spectrum of inflammatory phenotypes in asthma so that effective therapeutics targeting each asthma endotype can be developed.
No takes yet. Share an insight, caveat, or question.
Ai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: